Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma

Louis Picker, L. M. Weiss, L. J. Medeiros, G. S. Wood, R. A. Warnke

Research output: Contribution to journalArticle

317 Citations (Scopus)

Abstract

This study examines the immunohistologic profiles of a large series of histologically proven benign and malignant lymphoproliferative processes in order to define immunophenotypic criteria useful in the diagnosis of non-Hodgkin's lymphoma. Using a method of analysis relying solely on immunoarchitectural features of a given case, the authors were able to define immunologic criteria capable of differentiating benign from malignant lymphoid processes independent from conventional morphologic analysis. In general, these criteria involved identification of abnormal expression or loss of antigen in B- and T-lineage populations. Among B-lineage populations the following features were associated with malignant histology: 1) light-chain-restricted B lineage, 2) light chain- B lineage, 3) Leu-1+ B lineage, 4) L60+ B lineage, 5) 41H+ Ki-67+ B lineage), 6) loss of pan-B antigens, and 7) LFA-1- B lineage. Among T-cell populations outside the thymus, phenotypes associated with malignancy included 1) loss of pan-T antigens (including loss of the beta chain of the T-cell antigen receptor), 2) coexpression or loss of T-subset antigens, 3) Leu-6+ T-lineage, and 4) MB-1+ T lineage. Application of these criteria to a series of nearly 500 cases of lymphoma indicated that over 90% of B-lineage and about 80% of T-lineage neoplasms manifested immunophenotypic abnormalities that could distinguish them from benign, reactive lymphoid processes. It is concluded that immunophenotypic analysis of lymphoproliferative lesions is sufficiently sensitive and specific to confirm the histologic diagnosis of lymphoma in the vast majority of cases seen in clinical practice. Furthermore, in difficult cases or those with limited material or poor histology, immunophenotypic analysis may be the only means of making a definitive diagnosis.

Original languageEnglish (US)
Pages (from-to)181-201
Number of pages21
JournalAmerican Journal of Pathology
Volume128
Issue number1
StatePublished - 1987
Externally publishedYes

Fingerprint

Non-Hodgkin's Lymphoma
Viral Tumor Antigens
Lymphoma
Histology
B7 Antigens
Population
Antigen Receptors, T-Cell, alpha-beta
Light
Lymphocyte Function-Associated Antigen-1
Thymus Gland
Neoplasms
T-Lymphocytes
Phenotype
Antigens

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Picker, L., Weiss, L. M., Medeiros, L. J., Wood, G. S., & Warnke, R. A. (1987). Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. American Journal of Pathology, 128(1), 181-201.

Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. / Picker, Louis; Weiss, L. M.; Medeiros, L. J.; Wood, G. S.; Warnke, R. A.

In: American Journal of Pathology, Vol. 128, No. 1, 1987, p. 181-201.

Research output: Contribution to journalArticle

Picker, L, Weiss, LM, Medeiros, LJ, Wood, GS & Warnke, RA 1987, 'Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma', American Journal of Pathology, vol. 128, no. 1, pp. 181-201.
Picker, Louis ; Weiss, L. M. ; Medeiros, L. J. ; Wood, G. S. ; Warnke, R. A. / Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma. In: American Journal of Pathology. 1987 ; Vol. 128, No. 1. pp. 181-201.
@article{b6d390140ac04782867eb6257941e916,
title = "Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma",
abstract = "This study examines the immunohistologic profiles of a large series of histologically proven benign and malignant lymphoproliferative processes in order to define immunophenotypic criteria useful in the diagnosis of non-Hodgkin's lymphoma. Using a method of analysis relying solely on immunoarchitectural features of a given case, the authors were able to define immunologic criteria capable of differentiating benign from malignant lymphoid processes independent from conventional morphologic analysis. In general, these criteria involved identification of abnormal expression or loss of antigen in B- and T-lineage populations. Among B-lineage populations the following features were associated with malignant histology: 1) light-chain-restricted B lineage, 2) light chain- B lineage, 3) Leu-1+ B lineage, 4) L60+ B lineage, 5) 41H+ Ki-67+ B lineage), 6) loss of pan-B antigens, and 7) LFA-1- B lineage. Among T-cell populations outside the thymus, phenotypes associated with malignancy included 1) loss of pan-T antigens (including loss of the beta chain of the T-cell antigen receptor), 2) coexpression or loss of T-subset antigens, 3) Leu-6+ T-lineage, and 4) MB-1+ T lineage. Application of these criteria to a series of nearly 500 cases of lymphoma indicated that over 90{\%} of B-lineage and about 80{\%} of T-lineage neoplasms manifested immunophenotypic abnormalities that could distinguish them from benign, reactive lymphoid processes. It is concluded that immunophenotypic analysis of lymphoproliferative lesions is sufficiently sensitive and specific to confirm the histologic diagnosis of lymphoma in the vast majority of cases seen in clinical practice. Furthermore, in difficult cases or those with limited material or poor histology, immunophenotypic analysis may be the only means of making a definitive diagnosis.",
author = "Louis Picker and Weiss, {L. M.} and Medeiros, {L. J.} and Wood, {G. S.} and Warnke, {R. A.}",
year = "1987",
language = "English (US)",
volume = "128",
pages = "181--201",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Immunophenotypic criteria for the diagnosis of non-Hodgkin's lymphoma

AU - Picker, Louis

AU - Weiss, L. M.

AU - Medeiros, L. J.

AU - Wood, G. S.

AU - Warnke, R. A.

PY - 1987

Y1 - 1987

N2 - This study examines the immunohistologic profiles of a large series of histologically proven benign and malignant lymphoproliferative processes in order to define immunophenotypic criteria useful in the diagnosis of non-Hodgkin's lymphoma. Using a method of analysis relying solely on immunoarchitectural features of a given case, the authors were able to define immunologic criteria capable of differentiating benign from malignant lymphoid processes independent from conventional morphologic analysis. In general, these criteria involved identification of abnormal expression or loss of antigen in B- and T-lineage populations. Among B-lineage populations the following features were associated with malignant histology: 1) light-chain-restricted B lineage, 2) light chain- B lineage, 3) Leu-1+ B lineage, 4) L60+ B lineage, 5) 41H+ Ki-67+ B lineage), 6) loss of pan-B antigens, and 7) LFA-1- B lineage. Among T-cell populations outside the thymus, phenotypes associated with malignancy included 1) loss of pan-T antigens (including loss of the beta chain of the T-cell antigen receptor), 2) coexpression or loss of T-subset antigens, 3) Leu-6+ T-lineage, and 4) MB-1+ T lineage. Application of these criteria to a series of nearly 500 cases of lymphoma indicated that over 90% of B-lineage and about 80% of T-lineage neoplasms manifested immunophenotypic abnormalities that could distinguish them from benign, reactive lymphoid processes. It is concluded that immunophenotypic analysis of lymphoproliferative lesions is sufficiently sensitive and specific to confirm the histologic diagnosis of lymphoma in the vast majority of cases seen in clinical practice. Furthermore, in difficult cases or those with limited material or poor histology, immunophenotypic analysis may be the only means of making a definitive diagnosis.

AB - This study examines the immunohistologic profiles of a large series of histologically proven benign and malignant lymphoproliferative processes in order to define immunophenotypic criteria useful in the diagnosis of non-Hodgkin's lymphoma. Using a method of analysis relying solely on immunoarchitectural features of a given case, the authors were able to define immunologic criteria capable of differentiating benign from malignant lymphoid processes independent from conventional morphologic analysis. In general, these criteria involved identification of abnormal expression or loss of antigen in B- and T-lineage populations. Among B-lineage populations the following features were associated with malignant histology: 1) light-chain-restricted B lineage, 2) light chain- B lineage, 3) Leu-1+ B lineage, 4) L60+ B lineage, 5) 41H+ Ki-67+ B lineage), 6) loss of pan-B antigens, and 7) LFA-1- B lineage. Among T-cell populations outside the thymus, phenotypes associated with malignancy included 1) loss of pan-T antigens (including loss of the beta chain of the T-cell antigen receptor), 2) coexpression or loss of T-subset antigens, 3) Leu-6+ T-lineage, and 4) MB-1+ T lineage. Application of these criteria to a series of nearly 500 cases of lymphoma indicated that over 90% of B-lineage and about 80% of T-lineage neoplasms manifested immunophenotypic abnormalities that could distinguish them from benign, reactive lymphoid processes. It is concluded that immunophenotypic analysis of lymphoproliferative lesions is sufficiently sensitive and specific to confirm the histologic diagnosis of lymphoma in the vast majority of cases seen in clinical practice. Furthermore, in difficult cases or those with limited material or poor histology, immunophenotypic analysis may be the only means of making a definitive diagnosis.

UR - http://www.scopus.com/inward/record.url?scp=0023223910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023223910&partnerID=8YFLogxK

M3 - Article

VL - 128

SP - 181

EP - 201

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 1

ER -